Evaluation 18 ^th International Symposium on Neuropsychiatry & HIV

Practical focus on the diagnosis and treatment of the psychiatric and neuropsychological aspects of HIV infection

User information

Last name

First name

Please provide rating based upon a 5-point Likert scale (5 strongly agree, 1 strongly disagree)

Professional data

Country

City/Town

Speciality

Age

Full evaluation of Symposium

5 4 3 2 1

The topics are appropriate

5 4 3 2 1

The education will be useful for my work

5 4 3 2 1

The Symposium has satisfied my expectations

5 4 3 2 1

Balanced and scientifically supported information

5 4 3 2 1

Did all the faculty members provide their potential conflict of interest declaration with the sponsor(s) as a second slide of their presentation?

5 4 3 2 1

Do you agree that the information was overall free of commercial and other bias?

5 4 3 2 1

Impact

I intend to modify/change my clinical practice based on this educational activity

5 4 3 2 1

My office and practice systems can accommodate these changes

5 4 3 2 1

My patients can accommodate these changes

5 4 3 2 1

Patient access to the treatments provided will be a barrier to implementing these changes

5 4 3 2 1

On average, I utilized the patient treatment strategies described in this educational activity prior to my participation

5 4 3 2 1

Organization

The program is well organized

5 4 3 2 1

The length of the Symposium is correct

5 4 3 2 1

Discussion, questions & answers and learner engagement time is enough

5 4 3 2 1

The timetable is suitable

5 4 3 2 1

The virtual experience and quality of transmission

5 4 3 2 1

Communication

You knew about the Symposium through

The information received before the Symposium is enough

Yes No

Course Session

1.A Toolkit on psychopharmacology

Guida Da Ponte, M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

1.B Toolkit on psychopharmacology

Manuel Vélez, M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

2.A Use of long-acting medication – pharmacodynamics and pharmacokinetics neuropsychiatric toxicities

Ignacio Pérez-Valero, M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

2.B Use of long-acting medication – pharmacodynamics and pharmacokinetics neuropsychiatric toxicities

Catia Marzolini, Pharm.D., Ph.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

3.A Motivational Interview in psychiatric disorders and HIV care

Antoine Douaihy, M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

3.B Motivational Interview in psychiatric disorders and HIV care

Sylvie Naar, Ph.D., L.P.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

4.A How can physicians best measure the impact of HIV infection on the CNS?

Alan Winston, M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

4.B How can physicians best measure the impact of HIV infection on the CNS?

Andrea Calcagno, M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

4.C How can physicians best measure the impact of HIV infection on the CNS?

Simonetta Gerevini, M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Plenary lecture

Sleep disorders in people living with HIV

Robert Paul, Ph.D., ABPP-CN

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Clinical Case. Session 1

A. Full Reservoirs and Poor Adherence: A Case of Symptomatic HIV Cerebrospinal Fluid Escape with Tenofovir Alafenamide/Emtricitabine/Bictegravir.

Carola Lipani, M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

B. A young man’s fight against HIV since birth.

Carmen García-Martearena, M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

C. Lenecapavir in the context of relapsing neurosymptomatic cerebrospinal fluid HIV RNA escape.

Jesal Gohil, M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

D. Cluster headache-like symptoms after initiation of TDF and FTC-containing regimens for post-HIV exposure prophylaxis.

Alberto Foncillas, M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Clinical Case. Session 2

A. Limbic encephalitis following COVID-19 vaccination in HIV-positive patient.

Celia Cardozo, M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

B. Neurosyphilis with multiple cranial neuropathy revealing HIV infection.

José Henrique Pinho, M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

C. Malignant syphilis mimicking lymphoma in HIV patient: A diagnostic challege.

Chiara Maci, M.D.

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

Practical application of the topic in my work

5 4 3 2 1

Round table

The future of mental health in PWH (from research to implementation to clinical work)

Have you attended?

Yes No

The topic is appropriate

5 4 3 2 1

The information has been presented clearly

5 4 3 2 1

The round table encouraged reflection or dialogue

5 4 3 2 1

Open comment:

Comments

Symposium aspects to emphasize

Symposium aspects to improve

Proposal: interesting topics for the next edition

Observations and suggestions

Signature

Data

To sign on your desktop you can sign with your mouse.

To sign on your mobile or tablet you can sign with the same finger.

Signature

I have read and agree to the Privacy Policy.

The form has been sent successfully.

An error occured.

🕐 Please do not close or reload this page until the thank-you page has fully loaded.

Evaluation 18 th International Symposium on Neuropsychiatry & HIV

User information

Professional data

Full evaluation of Symposium

Contents

Impact

Organization

Communication

Course Session

1.A Toolkit on psychopharmacology

1.B Toolkit on psychopharmacology

2.A Use of long-acting medication – pharmacodynamics and pharmacokinetics neuropsychiatric toxicities

2.B Use of long-acting medication – pharmacodynamics and pharmacokinetics neuropsychiatric toxicities

3.A Motivational Interview in psychiatric disorders and HIV care

3.B Motivational Interview in psychiatric disorders and HIV care

4.A How can physicians best measure the impact of HIV infection on the CNS?

4.B How can physicians best measure the impact of HIV infection on the CNS?

4.C How can physicians best measure the impact of HIV infection on the CNS?

Plenary lecture

Sleep disorders in people living with HIV

Clinical Case. Session 1

A. Full Reservoirs and Poor Adherence: A Case of Symptomatic HIV Cerebrospinal Fluid Escape with Tenofovir Alafenamide/Emtricitabine/Bictegravir.

B. A young man’s fight against HIV since birth.

C. Lenecapavir in the context of relapsing neurosymptomatic cerebrospinal fluid HIV RNA escape.

D. Cluster headache-like symptoms after initiation of TDF and FTC-containing regimens for post-HIV exposure prophylaxis.

Clinical Case. Session 2

A. Limbic encephalitis following COVID-19 vaccination in HIV-positive patient.

B. Neurosyphilis with multiple cranial neuropathy revealing HIV infection.

C. Malignant syphilis mimicking lymphoma in HIV patient: A diagnostic challege.

Round table

Comments

Signature

Evaluation 18 ^th International Symposium on Neuropsychiatry & HIV